NORWAIT: “Watch and Wait” in patients with complete clinical response (cCR) after neo-adjuvant chemoradiotherapy for primary locally advanced rectal cancer

Trial Overview

AcronymNORWAIT
Numbern/a
Protocol Linkhttps://docs.wixstatic.com/ugd/758a26_bac251bb152348198d396e09a95d6aaf.pdf
Public Trial Registry Linkhttps://clinicaltrials.gov/ct2/show/NCT03402477
StatusOpen/recruiting
CategoryColorectal Cancer - Rectal Specific
Treatment CourseNeoadjuvant

Trial Description

National prospective cohort study aiming to reveal the true complete response rate in patients with clinical complete response after neo-adjuvant treatment for advanced rectal cancer in Norway. All patients who received neo-adjuvant treatment for rectal cancer according to Norwegian national guidelines who have a clinical complete response after 6-12 weeks are eligible for inclusion. By linking data of the NORWAIT trial to data from the Cancer Registry of Norway/Norwegian Colorectal Cancer Regis

Chief Investigator

Hartwig Kørner
MD, PhD, Professor of Surgery
Profile Link

Lead Centre

Stavanger University Hospital
Gerd-Ragna-Bloch gate 8
Stavanger
4011
Norway
Website

Additional Information

Full Research Summary
ESCP Affiliates